Analysts: Integra LifeSciences Holdings Corp (IART.OQ)
IART.OQ on NASDAQ Stock Exchange Global Select Market
38.61USD
1 Aug 2013
38.61USD
1 Aug 2013
Price Change (% chg)
$-0.78 (-1.98%)
$-0.78 (-1.98%)
Prev Close
$39.39
$39.39
Open
$39.50
$39.50
Day's High
$39.50
$39.50
Day's Low
$37.35
$37.35
Volume
69,154
69,154
Avg. Vol
46,431
46,431
52-wk High
$44.37
$44.37
52-wk Low
$30.89
$30.89
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 0.72 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 4 | 4 | 4 | 4 |
| (2) OUTPERFORM | 1 | 2 | 2 | 2 |
| (3) HOLD | 12 | 11 | 10 | 10 |
| (4) UNDERPERFORM | 1 | 1 | 1 | 1 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.56 | 2.50 | 2.47 | 2.47 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 15 | 214.79 | 220.30 | 210.00 | 222.36 |
| Quarter Ending Dec-13 | 15 | 224.66 | 233.35 | 219.50 | 230.99 |
| Year Ending Dec-13 | 16 | 843.17 | 848.00 | 831.40 | 873.14 |
| Year Ending Dec-14 | 16 | 891.58 | 911.10 | 876.00 | 926.11 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 14 | 0.72 | 0.80 | 0.64 | 0.85 |
| Quarter Ending Dec-13 | 14 | 0.86 | 0.94 | 0.76 | 0.92 |
| Year Ending Dec-13 | 15 | 2.52 | 2.69 | 2.35 | 3.20 |
| Year Ending Dec-14 | 15 | 3.19 | 3.51 | 2.75 | 3.61 |
| LT Growth Rate (%) | 8 | 11.04 | 25.00 | 6.00 | 11.80 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 197.67 | 196.65 | 1.02 | 0.51 |
| Quarter Ending Dec-12 | 215.91 | 214.43 | 1.48 | 0.68 |
| Quarter Ending Sep-12 | 211.43 | 210.08 | 1.35 | 0.64 |
| Quarter Ending Jun-12 | 205.36 | 210.20 | 4.84 | 2.36 |
| Quarter Ending Mar-12 | 192.75 | 196.18 | 3.44 | 1.78 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.45 | 0.39 | 0.06 | 13.47 |
| Quarter Ending Dec-12 | 0.77 | 0.78 | 0.01 | 0.87 |
| Quarter Ending Sep-12 | 0.76 | 0.85 | 0.09 | 12.03 |
| Quarter Ending Jun-12 | 0.69 | 0.74 | 0.06 | 8.03 |
| Quarter Ending Mar-12 | 0.60 | 0.71 | 0.11 | 17.43 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 214.79 | 214.79 | 214.79 | 214.89 | 222.36 |
| Quarter Ending Dec-13 | 224.66 | 224.66 | 224.66 | 224.79 | 230.99 |
| Year Ending Dec-13 | 843.17 | 843.17 | 843.17 | 843.21 | 873.14 |
| Year Ending Dec-14 | 891.58 | 891.58 | 891.58 | 891.76 | 926.11 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.72 | 0.72 | 0.72 | 0.72 | 0.85 |
| Quarter Ending Dec-13 | 0.86 | 0.86 | 0.86 | 0.86 | 0.92 |
| Quarter Ending Dec-13 | 2.52 | 2.52 | 2.52 | 2.51 | 3.20 |
| Quarter Ending Dec-14 | 3.19 | 3.19 | 3.19 | 3.19 | 3.61 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates